DE68909935T2 - Kontraststoffe für magnetische resonanzbildherstellung. - Google Patents

Kontraststoffe für magnetische resonanzbildherstellung.

Info

Publication number
DE68909935T2
DE68909935T2 DE89904039T DE68909935T DE68909935T2 DE 68909935 T2 DE68909935 T2 DE 68909935T2 DE 89904039 T DE89904039 T DE 89904039T DE 68909935 T DE68909935 T DE 68909935T DE 68909935 T2 DE68909935 T2 DE 68909935T2
Authority
DE
Germany
Prior art keywords
contrastics
magnetic resonance
resonance image
image production
production
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE89904039T
Other languages
English (en)
Other versions
DE68909935D1 (de
Inventor
Arne Berg
Jo Klaveness
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GE Healthcare AS
Original Assignee
Nycomed Imaging AS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nycomed Imaging AS filed Critical Nycomed Imaging AS
Application granted granted Critical
Publication of DE68909935D1 publication Critical patent/DE68909935D1/de
Publication of DE68909935T2 publication Critical patent/DE68909935T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01R—MEASURING ELECTRIC VARIABLES; MEASURING MAGNETIC VARIABLES
    • G01R33/00—Arrangements or instruments for measuring magnetic variables
    • G01R33/20—Arrangements or instruments for measuring magnetic variables involving magnetic resonance
    • G01R33/44—Arrangements or instruments for measuring magnetic variables involving magnetic resonance using nuclear magnetic resonance [NMR]
    • G01R33/48—NMR imaging systems
    • G01R33/54—Signal processing systems, e.g. using pulse sequences ; Generation or control of pulse sequences; Operator console
    • G01R33/56—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution
    • G01R33/5601—Image enhancement or correction, e.g. subtraction or averaging techniques, e.g. improvement of signal-to-noise ratio and resolution involving use of a contrast agent for contrast manipulation, e.g. a paramagnetic, super-paramagnetic, ferromagnetic or hyperpolarised contrast agent
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/101—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals
    • A61K49/103—Organic compounds the carrier being a complex-forming compound able to form MRI-active complexes with paramagnetic metals the complex-forming compound being acyclic, e.g. DTPA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/08—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by the carrier
    • A61K49/10—Organic compounds
    • A61K49/12—Macromolecular compounds
    • A61K49/126—Linear polymers, e.g. dextran, inulin, PEG
    • A61K49/128—Linear polymers, e.g. dextran, inulin, PEG comprising multiple complex or complex-forming groups, being either part of the linear polymeric backbone or being pending groups covalently linked to the linear polymeric backbone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
    • A61K49/18—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes
    • A61K49/1818—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles
    • A61K49/1821—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles
    • A61K49/1824—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles
    • A61K49/1827—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle
    • A61K49/1851—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule
    • A61K49/1863—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations characterised by a special physical form, e.g. emulsions, microcapsules, liposomes particles, e.g. uncoated or non-functionalised microparticles or nanoparticles coated or functionalised microparticles or nanoparticles coated or functionalised nanoparticles having a (super)(para)magnetic core, being a solid MRI-active material, e.g. magnetite, or composed of a plurality of MRI-active, organic agents, e.g. Gd-chelates, or nuclei, e.g. Eu3+, encapsulated or entrapped in the core of the coated or functionalised nanoparticle having a (super)(para)magnetic core coated or functionalised with an organic macromolecular compound, i.e. oligomeric, polymeric, dendrimeric organic molecule the organic macromolecular compound being a polysaccharide or derivative thereof, e.g. chitosan, chitin, cellulose, pectin, starch
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/24—Nuclear magnetic resonance, electron spin resonance or other spin effects or mass spectrometry
DE89904039T 1988-04-08 1989-04-06 Kontraststoffe für magnetische resonanzbildherstellung. Expired - Fee Related DE68909935T2 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB888808305A GB8808305D0 (en) 1988-04-08 1988-04-08 Compositions
PCT/EP1989/000376 WO1989009625A1 (en) 1988-04-08 1989-04-06 Contrast agents for magnetic resonance imaging

Publications (2)

Publication Number Publication Date
DE68909935D1 DE68909935D1 (de) 1993-11-18
DE68909935T2 true DE68909935T2 (de) 1994-03-17

Family

ID=10634845

Family Applications (1)

Application Number Title Priority Date Filing Date
DE89904039T Expired - Fee Related DE68909935T2 (de) 1988-04-08 1989-04-06 Kontraststoffe für magnetische resonanzbildherstellung.

Country Status (8)

Country Link
US (1) US5128121A (de)
EP (1) EP0414700B1 (de)
JP (1) JPH082802B2 (de)
AU (1) AU624132B2 (de)
DE (1) DE68909935T2 (de)
DK (1) DK239490D0 (de)
GB (1) GB8808305D0 (de)
WO (1) WO1989009625A1 (de)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX12394A (es) * 1987-07-23 1993-12-01 Ciba Geigy Ag Procedimiento par la obtencion de carbamatos de polietilenglicol.
GB8830215D0 (en) * 1988-12-23 1989-02-22 Hafslund Nycomed Innovation Method
US5393525A (en) * 1989-07-21 1995-02-28 Nycomed Imaging As Contrast medium comprising superparamagnetic or ferromagnetic particles capable of increasing viscosity after administration
US5190744A (en) * 1990-03-09 1993-03-02 Salutar Methods for detecting blood perfusion variations by magnetic resonance imaging
US5494655A (en) * 1990-03-09 1996-02-27 The Regents Of The University Of California Methods for detecting blood perfusion variations by magnetic resonance imaging
US5358702A (en) * 1990-04-10 1994-10-25 Unger Evan C Methoxylated gel particle contrast media for improved diagnostic imaging
GB9020075D0 (en) 1990-09-14 1990-10-24 Filler Aaron G Contrast agents for magnetic resonance imaging of axonal transport
ATE166233T1 (de) * 1990-09-14 1998-06-15 Syngenix Ltd Verwendung von substanzen in partikelform
US5948384A (en) * 1990-09-14 1999-09-07 Syngenix Limited Particulate agents
US6919067B2 (en) 1991-09-13 2005-07-19 Syngenix Limited Compositions comprising a tissue glue and therapeutic agents
US5282827A (en) * 1991-11-08 1994-02-01 Kensey Nash Corporation Hemostatic puncture closure system and method of use
US5676689A (en) * 1991-11-08 1997-10-14 Kensey Nash Corporation Hemostatic puncture closure system including vessel location device and method of use
CA2121681A1 (en) * 1991-11-19 1993-05-27 Evan C. Unger Gel particle contrast media for improved diagnostic imaging
DE4218321A1 (de) * 1991-12-09 1993-06-17 Siemens Ag Diagnostikanlage
WO1993025895A1 (en) * 1992-06-15 1993-12-23 Board Of Regents, The University Of Texas System Clay enclosed transition and rare earth metal ions as contrast agents for the gastrointestinal tract
US5323780A (en) * 1992-08-07 1994-06-28 University Of Florida Research Foundation, Inc. Artifact-free imaging contrast agent
US5532006A (en) * 1993-04-23 1996-07-02 The Board Of Trustees Of The University Of Illinois Magnetic gels which change volume in response to voltage changes for MRI
GB9314499D0 (en) * 1993-07-12 1993-08-25 Nycomed Imaging As Method
US5804561A (en) * 1993-08-16 1998-09-08 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5840701A (en) * 1993-08-16 1998-11-24 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5725839A (en) * 1993-08-16 1998-03-10 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules for ERI or MRI
US5824781A (en) * 1993-08-16 1998-10-20 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5817632A (en) * 1993-08-16 1998-10-06 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5741893A (en) * 1993-08-16 1998-04-21 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
US5767089A (en) * 1993-08-16 1998-06-16 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
TW381022B (en) 1993-08-16 2000-02-01 Hsia Jen Chang Compositions and methods utilizing nitroxides to avoid oxygen toxicity, particularly in stabilized, polymerized, conjugated, or encapsulated hemoglobin used as a red cell substitute
US5807831A (en) * 1993-08-16 1998-09-15 Hsia; Jen-Chang Compositions and methods utilizing nitroxides in combination with biocompatible macromolecules
EP0650738B1 (de) 1993-10-28 2003-05-02 Medrad, Inc. System zur Administration von Flüssigkeiten bei mehreren Patienten
EP1258262A3 (de) 1993-10-28 2002-12-18 Medrad, Inc. System zur Kontrastmittelabgabe
GB9416767D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
GB9416768D0 (en) * 1994-08-18 1994-10-12 Nycomed Innovation Ab Compositions
US5863519A (en) * 1994-08-18 1999-01-26 Nycomed Imaging As Composition and method of MRI using both a positive and a negative contrast agent
US5840026A (en) * 1994-09-21 1998-11-24 Medrad, Inc. Patient specific dosing contrast delivery systems and methods
GB9420390D0 (en) * 1994-10-10 1994-11-23 Nycomed Salutar Inc Liposomal agents
DK81095A (da) * 1995-07-11 1997-01-12 Henrik S Thomsen Peroralt MR-kontraststof til lever og øvre tarmkanal
US7169410B1 (en) * 1998-05-19 2007-01-30 Sdg, Inc. Targeted liposomal drug delivery system
WO2000009170A1 (en) * 1998-08-10 2000-02-24 Bracco Research S.A. Combination of a positive mri contrast agent with a negative mri contrast agent
EP0988864A1 (de) * 1998-09-23 2000-03-29 Luboldt, Wolfgang, Dr.med. Dipl.-Phys. Kontrastmittel für die Magnetresonanztomographie
US7871597B2 (en) 1999-04-09 2011-01-18 Amag Pharmaceuticals, Inc. Polyol and polyether iron oxide complexes as pharmacological and/or MRI contrast agents
DK1169062T3 (da) * 1999-04-09 2010-01-25 Amag Pharmaceuticals Inc Varmestabile overtrukne kolloide jernoxider
CZ2002343A3 (cs) * 1999-07-29 2002-08-14 Epix Medical, Inc. Cílená multimerní zobrazovací činidla s multilokální vazebnou schopností
US20030120151A1 (en) * 2001-01-10 2003-06-26 Johns Hopkins University Magnetic resonance imaging methods and compositions
US8961541B2 (en) 2007-12-03 2015-02-24 Cardio Vascular Technologies Inc. Vascular closure devices, systems, and methods of use
US8992567B1 (en) 2001-04-24 2015-03-31 Cardiovascular Technologies Inc. Compressible, deformable, or deflectable tissue closure devices and method of manufacture
US20080109030A1 (en) 2001-04-24 2008-05-08 Houser Russell A Arteriotomy closure devices and techniques
US6934574B1 (en) * 2001-06-21 2005-08-23 Fonar Corporation MRI scanner and method for modular patient handling
TWI221406B (en) * 2001-07-30 2004-10-01 Epix Medical Inc Systems and methods for targeted magnetic resonance imaging of the vascular system
US6944492B1 (en) 2001-10-01 2005-09-13 Fonar Corporation Patient bed support for an open MRI system
US7109974B2 (en) * 2002-03-05 2006-09-19 Matsushita Electric Industrial Co., Ltd. Remote control system including an on-screen display (OSD)
EP1812101A4 (de) * 2004-11-16 2014-04-23 Medrad Inc Modellierung von pharmazeutischer verbreitung
EP2990073B1 (de) 2004-11-24 2018-05-02 Bayer Healthcare LLC Vorrichtungen und systeme zur flüssigkeitsabgabe
US8023172B2 (en) * 2006-08-30 2011-09-20 Silicon Quest Kabushiki-Kaisha Mirror device
JP2010514506A (ja) * 2006-12-29 2010-05-06 メドラッド インコーポレーテッド 薬剤伝搬のモデリング
EP3376504A1 (de) 2006-12-29 2018-09-19 Bayer Healthcare, LLC Patientenbasierte parametergenerierungssysteme für medizinische injektionsverfahren
US8195275B2 (en) * 2007-05-23 2012-06-05 Siemens Aktiengesellschaft Vessel size imaging for antiangiogenic therapy
EP2005970A1 (de) 2007-06-22 2008-12-24 Berlin Science Partners GmbH i.V. Bildgebende Diagnostik durch Kombination von Kontrastmitteln
US8428694B2 (en) * 2007-07-17 2013-04-23 Medrad, Inc. Methods for determination of parameters for a procedure, for estimation of cardiopulmonary function and for fluid delivery
WO2009012288A2 (en) * 2007-07-17 2009-01-22 Government Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Trifunctional imaging agent for monoclonal antibody tumor-targeted imaging
US8608484B2 (en) * 2008-03-04 2013-12-17 Medrad, Inc. Dynamic anthropomorphic cardiovascular phantom
US8315449B2 (en) * 2008-06-24 2012-11-20 Medrad, Inc. Identification of regions of interest and extraction of time value curves in imaging procedures
US9421330B2 (en) 2008-11-03 2016-08-23 Bayer Healthcare Llc Mitigation of contrast-induced nephropathy
CN104739461A (zh) 2009-04-09 2015-07-01 心血管科技股份有限公司 组织封闭装置、输送装置和系统、用于其的套件和方法
EP2585116A4 (de) 2010-06-24 2017-03-29 Bayer Healthcare LLC Modellierung einer pharmazeutikumsausbreitung und parametererstellung für injektionsprotokolle
JP2014527881A (ja) 2011-09-21 2014-10-23 ベイヤー メディカル ケア インク． 連続多流体ポンプ装置、駆動および作動システムならびに方法
FR2986332A1 (fr) * 2012-01-30 2013-08-02 Centre Nat Rech Scient Nanoparticules a luminescence persistante pour l'imagerie optique en temps reel, l'imagerie multimodale optique-irm in vivo, et la theranostique
CA2873351C (en) 2012-05-14 2022-07-26 Bayer Medical Care Inc. Systems and methods for determination of pharmaceutical fluid injection protocols based on x-ray tube voltage
US9555379B2 (en) 2013-03-13 2017-01-31 Bayer Healthcare Llc Fluid path set with turbulent mixing chamber, backflow compensator
RU2714926C2 (ru) 2015-01-09 2020-02-21 БАЙЕР ХелсКер ЛЛСи Многофлюидная система доставки с многоразовым расходным комплектом и ее конструкционные особенности
WO2017152036A1 (en) 2016-03-03 2017-09-08 Bayer Healthcare Llc System and method for improved fluid delivery in multi-fluid injector systems
WO2019046260A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc METHOD FOR CONTROLLING DYNAMIC PRESSURE IN A FLUID INJECTOR SYSTEM
US11478581B2 (en) 2017-08-31 2022-10-25 Bayer Healthcare Llc Fluid injector system volume compensation system and method
CA3067740A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc Method for drive member position and fluid injection system mechanical calibration
WO2019046282A1 (en) 2017-08-31 2019-03-07 Bayer Healthcare Llc SYSTEM AND METHOD FOR INJECTOR PRESSURE CALIBRATION
US11141535B2 (en) 2017-08-31 2021-10-12 Bayer Healthcare Llc Fluid path impedance assessment for improving fluid delivery performance

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3731377A (en) * 1971-08-19 1973-05-08 W Muckelroy Method for handling beam-lead and odd-shaped semi-conductor devices
JPS53130572A (en) * 1977-04-05 1978-11-14 Tdk Electronics Co Ltd Highhgradient magnetic separator using amorphous magnetic alloy
US4735796A (en) * 1983-12-08 1988-04-05 Gordon Robert T Ferromagnetic, diamagnetic or paramagnetic particles useful in the diagnosis and treatment of disease
US4590922A (en) * 1983-08-19 1986-05-27 Gordon Robert T Use of ferromagnetic, paramagnetic and diamagnetic particles in the treatment of infectious diseases
GB8408127D0 (en) * 1984-03-29 1984-05-10 Nyegaard & Co As Contrast agents
GB8413772D0 (en) * 1984-05-30 1984-07-04 Nyegaard & Co As Chemical compounds
US4889120A (en) * 1984-11-13 1989-12-26 Gordon Robert T Method for the connection of biological structures
US4827945A (en) * 1986-07-03 1989-05-09 Advanced Magnetics, Incorporated Biologically degradable superparamagnetic materials for use in clinical applications
US4813399A (en) * 1986-07-18 1989-03-21 Gordon Robert T Process for the treatment of neurological or neuromuscular diseases and development

Also Published As

Publication number Publication date
DK239490A (da) 1990-10-04
JPH082802B2 (ja) 1996-01-17
US5128121A (en) 1992-07-07
AU624132B2 (en) 1992-06-04
WO1989009625A1 (en) 1989-10-19
AU3359889A (en) 1989-11-03
DK239490D0 (da) 1990-10-04
GB8808305D0 (en) 1988-05-11
DE68909935D1 (de) 1993-11-18
EP0414700B1 (de) 1993-10-13
EP0414700A1 (de) 1991-03-06
JPH03503612A (ja) 1991-08-15

Similar Documents

Publication Publication Date Title
DE68909935T2 (de) Kontraststoffe für magnetische resonanzbildherstellung.
DE68907278D1 (de) Supraleitender magnetresonanz-magnet.
DE3853027D1 (de) Zwei-Frequenzen NMR Oberflächenspule.
DE69019579T2 (de) Spulensystem für einen Kernspinresonazapparat zur Abbildung.
DE3854177T2 (de) Planarspule.
FI863407A0 (fi) Magnetisk resonansavbildningsapparat innehaollande magnetiska element avsedda foer faelthomogenisering.
DE69029692D1 (de) Magnetresonanzabbildung
IT1229835B (it) Complesso di fissaggio magnetico.
DE68922457D1 (de) Ein Supraleiter zur Magnetfeldabschirmung.
DE69028962T2 (de) Magnetresonanzsysteme
DE3750351T4 (de) Magnetischer Toner.
DE68916666D1 (de) Magnetischer Toner.
DE3482207D1 (de) Kryostat fuer die magnetische kernresonanz.
DE69130590T2 (de) Magnetsystem für Kernspinresonanz
DE69013227T2 (de) Magnetkern.
DE3853473D1 (de) Magnetische brückenanordnungen.
DE3851510D1 (de) Spulenanordnungen für einen magnetischen Resonanzapparat.
DE69017343T2 (de) Magnetischer Toner.
DE3668989D1 (de) Kernmagnetisches resonanzsystem.
DE68912880D1 (de) Magnetkerne.
DE69100611T2 (de) Kompakte Sonde für die magnetische Kernresonanz.
DE3854317D1 (de) Magnetische Karte.
DE3785010T2 (de) Eichkoerper fuer magnetische kernresonanz-diagnose.
DE3875530D1 (de) Nuklearmagnetischer resonanz-magnetfeldmesser.
FR2619954B3 (fr) Bobine pour electro-aimants

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee